Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Aclaris Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -22.2 M, a 22.72% increase year-over-year.
• Aclaris Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -75.8 M, a 2.71% increase year-over-year.
• Aclaris Therapeutics, Inc. annual operating income for 2025 was -76.4 M, a 46.19% decrease from 2024.
• Aclaris Therapeutics, Inc. annual operating income for 2024 was -141.9 M, a 45.79% increase from 2023.
• Aclaris Therapeutics, Inc. annual operating income for 2023 was -97.4 M, a 8.35% increase from 2022.
• Aclaris Therapeutics, Inc. annual operating income for 2022 was -89.9 M.